DEA Extends Telemedicine Exceptions Through Dec. 31, 2024



Having trouble viewing this email? View it as a Web page [ [link removed] ].


announcement - washington medical commission
DEA Extends Telemedicine Exceptions
Through Dec. 31, 2024

In response to ongoing discussions and feedback, the Drug Enforcement Administration (DEA) DEA and Department of Health and Human Services (HHS) have issued a "second temporary rule". This rule extends exceptions, first created due COVID in 2020, to existing DEA regulations for new practitioner-patient relationships.

The decision to extend these exceptions comes as the DEA and HHS continue to review and consider revisions to the proposed rules.

*Exceptions are extended on current telemedicine flexibilities through December 31, 2024.* The full text of the extension, entitled ?Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications [ [link removed] ],? was submitted to the Federal Register jointly with HHS on September 29.





Facebook [ [link removed] ]Twitter [ [link removed] ]Mail <[email protected]>


? Washington Medical Commission. All right reserved.

Manage Subscription [ [link removed] ] ?|? Subscriber Help [ [link removed] ] ?|? Contact Us [ [link removed] ]





________________________________________________________________________

? GovDelivery logo [ [link removed] ]